Waddell & Associates’s Incyte INCY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.19M Buy
10,470
+759
+8% +$75.3K 0.06% 115
2026
Q1
$914K Buy
9,711
+113
+1% +$11.3K 0.05% 121
2025
Q4
$948K Buy
9,598
+703
+8% +$68K 0.06% 96
2025
Q3
$754K Buy
8,895
+1,234
+16% +$97.5K 0.06% 90
2025
Q2
$522K Buy
+7,661
New +$485K 0.06% 105

Other funds holding INCY

Waddell & Associates's INCY Position: Q2 2026 in Review

Waddell & Associates increased its Incyte (INCY) stake by 7.8% in Q2 2026, buying an estimated $75.3K and bringing the position to 10,470 shares worth $1.19M. The position accounts for 0.06% of the portfolio, ranked #115.

Waddell & Associates first reported a position in INCY in Q2 2025 and has held it in 5 quarters since. 142 funds tracked by Wall St. Rank hold INCY as of Q2 2026.

  • Waddell & Associates held 10,470 shares of Incyte worth $1.19M as of Q2 2026.
  • Waddell & Associates bought 759 Incyte shares in Q2 2026, an estimated $75.3K.
  • Incyte made up 0.06% of Waddell & Associates's portfolio in Q2 2026, its #115 holding.
  • Waddell & Associates first reported a position in Incyte in Q2 2025 and has held it in 5 quarters since.
  • 142 funds tracked by Wall St. Rank held Incyte as of Q2 2026.

Based on Waddell & Associates's 13F filing for Q2 2026, filed 15 Jul 2026.